Back

Safety, pharmacodynamic and pharmacokinetic characterisation of vericiguat: key results from six phase I studies in healthy subjects

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Pharmacology and Pharmacotherapy Cardiovascular Pharmacotherapy, Other HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Corina Becker

Bayer AG, Wuppertal (Germany)

12 More presentations in this session

Presentation thumbnail
Doctor J. Fallon (Cleveland, US)
Abstract Slides
Presentation thumbnail
Mr C. Moliner-Abos (Barcelona, ES)
Abstract
Presentation thumbnail
Doctor J. De Almeida (Coimbra, PT)
Abstract
Presentation thumbnail
Professor M. Ledwidge (Dublin, IE)
Abstract
Presentation thumbnail
Doctor S. Del Prado Diaz (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Pharmacology and Pharmacotherapy

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources